Remdesivir is considered to be the most effective medicine in the treatment of Covid-19 worldwide. The drug is manufactured

New Delhi: Remdesivir is considered to be the most effective medicine in the treatment of Covid-19 worldwide. The drug is manufactured by Gilead Sciences, an American pharmaceutical company. The company also supplies the drug to 127 countries around the world, including India.

Remdesivir

The drug will now be manufactured by an Indian company. For this, Gilead Sciences has set up a pharmaceutical company in Hyderabad, India. According to a non-executive agreement between US and Indian companies, Gilead Sciences has been given the authority to register and manufacture the treatment.

The Indian pharmaceutical manufacturer Zydus Cadila said that Gilead Sciences Dr. Reddy will also transfer technology. Dr. Reddy will need regulatory approvals to increase production and marketing of the drug in the countries concerned. Remdesivir has already received approval from the US Food and Drug Administration (USFDA) for the treatment of Covid-19.

Remedisvir is considered to be the most effective medicine of Corona. The World Health Organization (WHO) has also sealed the use of it for the treatment of Ebola. Remdesivir is part of the WHO's solidarity test.

RemdesivirHowever, the antiviral drug will not be available in the Indian market this month, even after the process of permitting the production of Remdesivir in India has accelerated. According to Health Ministry sources, Hetero Labs Ltd will submit the results of its test reports and stability data in the last week of June.

Hetero Labs is one of the four companies that have signed a license agreement to manufacture and supply a general version of Remdesivir in India. Based on the results of test reports and stability data, Indian manufacturers will be given approval for its controlled emergency use as it was given to Gilead Sciences of USA.